Control (n = 20)

Cases (n = 40)

p

Significance

Mild MS (n = 9)

Moderate MS (n = 31)

LAX-LSS%

−20.20 ± 1.94

−17.0^a ± 1.22

−14.19^ab ± 1.30

<0.001*

S

4C-LSS%

−20.55 ± 1.57

−17.11^a ± 1.36

−14.35^ab ± 1.25

<0.001*

S

2C-LSS%

−18.90 ± 2.25

−16.0 ± 1.22

−13.45^ab ± 1.18

<0.001*

S

GLSS%

−19.88 ± 1.57

−16.73^a ± 1.26

−14.02^ab ± 1.23

<0.001*

S

LAX-LSSr s–1

−1.38 ± 0.14

−1.09^a ± 0.02

−1.05^ab ± 0.03

<0.001*

S

4C-LSSr s–1

−1.40 ± 0.14

−1.10^a ± 0.03

−1.09^ab ± 0.18

<0.001*

S

2C-LSSr s–1

−1.37 ± 0.14

−1.08^a ± 0.02

−1.04^ab ± 0.03

<0.001*

S

GLSSr s–1

−1.38 ± 0.14

−1.09^a ± 0.02

−1.06^ab ± 0.06

<0.001*

S

APM-LS%

−24.35 ± 1.42

−18.44^a ± 1.13

−15.10^ab ± 1.76

<0.001*

S

PPM-LS%

−23.05 ± 1.32

−16.44^a ± 0.88

−14.03^ab ± 1.33

<0.001*

S